What is CONMED Corporation's Market Cap?

CONMED Corporation's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's Enterprise Value?

CONMED Corporation's Enterprise Value is $2.3B, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's Trailing P/E?

CONMED Corporation's Trailing P/E is 26.1×, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's Price / Sales?

CONMED Corporation's Price / Sales is 1.1×, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's EV / Revenue?

CONMED Corporation's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's EV / EBITDA?

CONMED Corporation's EV / EBITDA is 14.0×, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's Revenue (TTM)?

CONMED Corporation's Revenue (TTM) is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's Net Income (TTM)?

CONMED Corporation's Net Income (TTM) is $56.5M, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's EBITDA?

CONMED Corporation's EBITDA is $162.4M, based on as-reported figures from SEC (XBRL) filings.

What is CONMED Corporation's Diluted EPS (TTM)?

CONMED Corporation's Diluted EPS (TTM) is 1.89, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

CONMED Corporation

XNYS · usd

SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

FIGI BBG001S5PZH2

49.25▼ 0.19 (-0.38%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 49.44
Day's Range: 48.31 – 49.72
52-Week Range: 31.44 – 53.66
Volume: 343.1K
Avg Volume: 388.8K

Share Statistics

Shares Outstanding
Employees: 3,900
Exchange: XNYS
Listed: 1987-07-23

Share count as of July 27, 2026

CONMED Corporation (CNMD) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about CONMED Corporation (CNMD)

What is CONMED Corporation's Market Cap?: CONMED Corporation's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Enterprise Value?: CONMED Corporation's Enterprise Value is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Trailing P/E?: CONMED Corporation's Trailing P/E is 26.1×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Price / Sales?: CONMED Corporation's Price / Sales is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's EV / Revenue?: CONMED Corporation's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's EV / EBITDA?: CONMED Corporation's EV / EBITDA is 14.0×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Revenue (TTM)?: CONMED Corporation's Revenue (TTM) is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Net Income (TTM)?: CONMED Corporation's Net Income (TTM) is $56.5M, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's EBITDA?: CONMED Corporation's EBITDA is $162.4M, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Diluted EPS (TTM)?: CONMED Corporation's Diluted EPS (TTM) is 1.89, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CNMDAs-filed SEC (XBRL) data